advertising
-
1
Margolis DJ, Malay DS, Hoffstad OJ, et al: “Economic Burden of Diabetic Foot Ulcers and Amputations,” in Data Points Publication Series [Internet], Agency for Healthcare Research and Quality, Rockville, MD, 2011.
-
2
Rice JB, Desai U, Cummings AKG, et al: Burden of diabetic foot ulcers for Medicare and private insurers. Diabetes Care 37: 651, 2014.
-
3
Hicks CW, Selvarajah S, Mathioudakis N, et al: Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers. J Vasc Surg 60: 1247, 2014.
-
4
Hicks CW, Selvarajah S, Mathioudakis N, et al: Burden of infected diabetic foot ulcers on hospital admissions and costs. Ann Vasc Surg 33: 149, 2016.
-
5
Skrepnek GH, Mills JL, Armstrong DG: A diabetic emergency one million feet long: disparities and burdens of illness among diabetic foot ulcer cases within emergency departments in the United States, 2006–2010. PLoS One 10: e0134914, 2015.
-
6
Wukich DK, Hobizal KB, Brooks MM: Severity of diabetic foot infection and rate of limb salvage. Foot Ankle Int 34: 351, 2013.
-
7
Driver VR, Fabbi M, Lavery LA, et al: The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg 52: 17S, 2010.
-
8
Nirantharakumar K, Saeed M, Wilson I, et al: In-hospital mortality and length of stay in patients with diabetes having foot disease. J Diabetes Complications 27: 454, 2013.
-
9
Kerr M, Barron E, Chadwick P, et al: The cost of diabetic foot ulcers and amputations to the National Health Service in England. Diabet Med 36: 995, 2019.
-
10
Younger AS, Awwad MA, Kalla TP, et al: Risk factors for failure of transmetatarsal amputations in diabetic patients: a cohort study. Foot Ankle Int 30: 1177, 2009.
-
11
Suh YC, Kushida-Contreras BH, Suh HP, et al: Is reconstruction preserving the first ray or first two rays better than full transmetatarsal amputation in diabetic foot? Plast Reconstr Surg 143: 294, 2019.
-
12
Kaiser P, Häller TV, Uçkay I, et al: Revision after total transmetatarsal amputation. J Foot Ankle Surg 58: 1171, 2019.
-
13
Thorud JC, Jupiter DC, Lorenzana J, et al: Reoperation and reamputation after transmetatarsal amputation: a systematic review and meta-analysis. J Foot Ankle Surg 55: 1007, 2016.
-
14
Mandolfino T, Canciglia A, Salibra M, et al: Functional outcomes of transmetatarsal amputation in the diabetic foot: timing of revascularization, wound healing and ambulatory status. Updates Surg 68: 401, 2016.
-
15
Ahn J, Raspovic KM, Liu GT, et al: Renal function as a predictor of early transmetatarsal amputation failure. Foot Ankle Spec 12: 439, 2019.
-
16
Kantar RS, Alfonso AR, Rifkin WJ, et al: Risk factors for wound complications following transmetatarsal amputation in patients with diabetes. J Surg Res 243: 509, 2019.
-
17
Pollard J, Hamilton GA, Rush SM, et al: Mortality and morbidity after transmetatarsal amputation: retrospective review of 101 cases. J Foot Ankle Surg 45: 91, 2006.
-
18
Arya S, Binney ZO, Khakharia A, et al: High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization. J Vasc Surg 67: 217, 2018.
-
19
Acar E, Kacıra BK: Predictors of lower extremity amputation and reamputation associated with the diabetic foot. J Foot Ankle Surg 56: 1218, 2017.
-
20
Hicks CW, Canner JK, Karagozlu H, et al: Contribution of 30-day readmissions to the increasing costs of care for the diabetic foot. J Vasc Surg 70: 1263, 2019.
-
21
Holscher CM, Hicks CW, Canner JK, et al: Unplanned 30-day readmission in patients with diabetic foot wounds treated in a multidisciplinary setting. J Vasc Surg 67: 876, 2018.
-
22
Beaulieu RJ, Grimm JC, Lyu H, et al: Rates and predictors of readmission after minor lower extremity amputations. J Vasc Surg 62: 101, 2015.
-
23
Tabur S, Eren MA, Çelik Y, et al: The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration. Wien Klin Wochenschr 127: 45, 2015.
-
24
Choi SK, Kim CK, Jo DI, et al: Factors associated with a prolonged length of hospital stay in patients with diabetic foot: a single-center retrospective study. Arch Plast Surg 44: 539, 2017.
-
25
Kim TG, Moon SY, Park MS, et al: Factors affecting length of hospital stay and mortality in infected diabetic foot ulcers undergoing surgical drainage without major amputation. J Korean Med Sci 31: 120, 2016.
-
26
Wukich DK, Hobizal KB, Sambenedetto TL, et al: Outcomes of osteomyelitis in patients hospitalized with diabetic foot infections. Foot Ankle Int 37: 1285, 2016.
-
27
Kote GS, Bhat AN, Thajuddeen K, et al: Peripheral insensate neuropathy: is height a risk factor? J Clin Diagn Res 7: 296, 2013.
-
28
Cheng YJ, Gregg EW, Kahn HS, et al: Peripheral insensate neuropathy: a tall problem for US adults? Am J Epidemiol 164: 873, 2006.
-
29
Sorensen L, Molyneaux L, Yue DK: Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control. Diabetes Res Clin Pract 57: 45, 2002.
-
30
Fu X, Zhao S, Mao H, et al: Association of height with peripheral arterial disease in type 2 diabetes. J Endocrinol Invest 38: 57, 2015.
-
31
Ferriol C, Tremols S, Jimenez C, et al: Are there height-dependent differences in subclinical vascular disease in hypertensive patients? J Clin Hypertens 16: 70, 2014.
-
32
Menez S, Kwak L, Ding N, et al: The association of height with incident peripheral arterial disease in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 139 (suppl_1): AP308, 2019.
-
33
Roetker NS, Armasu SM, Pankow JS, et al: Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis. J Thromb Haemost 15: 1334, 2017.
-
34
Bjornerem A, Bui QM, Ghasem-Zadeh A, et al: Fracture risk and height: an association partly accounted for by cortical porosity of relatively thinner cortices. J Bone Miner Res 28: 2017, 2013.
-
35
User Guide for the 2018 ACS NSQIP Participant Use Data File. Available at: https://www.facs.org/media/1nrdyqmr/nsqip_puf_userguide_2022.pdf. Accessed April 14, 2020.
A Comparison of Adverse Short-Term Outcomes After Forefoot Amputation Based on Patient Height
Search for other papers by Kushkaran Kaur in
Current site
Google Scholar
PubMed
Search for other papers by Rhonda S. Cornell in
Current site
Google Scholar
PubMed
Search for other papers by Andrew J. Meyr in
Current site
Google Scholar
PubMed
Background: The objective of this investigation was to evaluate adverse short-term outcomes after partial forefoot amputation with a specific comparison performed based on patient height.
Methods: The American College of Surgeons National Surgical Quality Improvement Program database was analyzed to select patients with a 28805 Current Procedural Terminology code (amputation, foot; transmetatarsal) who underwent the procedure with “all layers of incision (deep and superficial) fully closed.” This resulted in 11 patients with a height of 60 inches or less, 202 with a height greater than 60 inches and less than 72 inches, and 55 with a height of 72 inches or greater.
Results: Results of the primary outcome measures found no significant differences among groups with respect to the development of a superficial surgical site infection (0% versus 6.4% versus 5.5%; P = .669), deep incisional infection (9.1% versus 3.5% versus 10.9%; P = .076), or wound disruption (0% versus 5.4% versus 5.5%; P = .730). In addition, no significant differences were observed among groups with respect to unplanned reoperations (9.1% versus 16.8% versus 12.7%; P = .630) or unplanned hospital readmissions (45.5% versus 23.3% versus 20.0%; P = .190).
Conclusions: The results of this investigation demonstrate no differences in short-term adverse outcomes after partial forefoot amputation with primary closure based on patient height. Although height has previously been described as a potential risk factor in the development of lower-extremity pathogenesis, this finding was not observed in this study from a large US database.
advertising
